Epstein David R

SEC Form 4 insider trading activity

Epstein David R has filed 12 SEC Form 4 filings (14 transaction rows) across 2 companies, including AGMB, TEM, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Oct 22, 2026.

On the most recent filing, Epstein David R is listed as Director at AgomAb Therapeutics NV. Inside the rolling window, Epstein David R reported 4 open-market purchases totaling $220K in AGMB and 7 open-market sales totaling $132K in TEM. The largest disclosed transaction in the window is a purchase of 10,000 AGMB shares on Oct 21, 2026, worth $89K.

Companies traded

Other insiders at AGMB

Insider Buying

$220K

reported purchases (SEC code P)

Insider Selling

$132K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
AGMBPurchase$89KOct 22SEC ↗
AGMBPurchase$45KOct 9SEC ↗
AGMBPurchase$43KOct 7SEC ↗
AGMBPurchase$44KOct 7SEC ↗
TEMSale$16KSep 3SEC ↗
TEMSale$16KAug 5SEC ↗
TEMSale$12KJun 3SEC ↗
TEMSale$13KMar 4SEC ↗
TEMSale$22KFeb 4SEC ↗
TEMSale$19KDec 3SEC ↗
TEMSale$33KNov 5SEC ↗
Showing 1–11 of 11
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 2, 2025TEMSale$18K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Epstein David R made?

Epstein David R has filed 12 SEC Form 4 filings (14 transaction rows) across 2 companies, including AGMB, TEM since 2025.

Which companies does Epstein David R trade?

Epstein David R has filed SEC Form 4 disclosures for 2 companies, including AGMB, TEM.

When was Epstein David R's most recent SEC Form 4 filing?

Epstein David R's most recent SEC Form 4 filing on Tracefour is dated Oct 22, 2026.

What is Epstein David R's total buy and sell value in the current window?

Inside the rolling retention window, Epstein David R bought $220K and sold $132K based on SEC Form 4 filings.

What was Epstein David R's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 10,000 AGMB shares on 2026-10-21, worth $89K, per SEC Form 4 filings.